Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522960 | SCV000620718 | pathogenic | not provided | 2017-09-15 | criteria provided, single submitter | clinical testing | The S1094X variant in the KIF7 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The S1094X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret S1094X as a pathogenic variant. |
Labcorp Genetics |
RCV001381328 | SCV001579654 | pathogenic | Acrocallosal syndrome | 2020-10-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with KIF7-related conditions. ClinVar contains an entry for this variant (Variation ID: 451951). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser1094*) in the KIF7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KIF7 are known to be pathogenic (PMID: 19666503, 21552264, 21633164, 26648833). |